Verbal Memory Training Using Virtual Reality in Schizophrenia
1 other identifier
interventional
30
1 country
1
Brief Summary
Verbal episodic memory is an independent declarative memory system associated with language and is responsible for storage and conscious recall of previous personal experiences. Verbal episodic memory is impaired in schizophrenia and is related to patients' functional outcomes. Because no medication has shown clear positive effects on verbal memory impairment in schizophrenia, there is a great need to find effective cognitive remediation treatments (CRT) that could improve this domain in this psychiatric population. Although CRT programs have shown small to moderate positive effects on verbal memory in individuals with schizophrenia, traditional lab-based computerised cognitive interventions have notable attrition rates. In recent years, along with the advancement of technology, the development of Virtual Reality (VR) has allowed the possibility for new training techniques. Previous studies have established the initial feasibility and safety of using VR in schizophrenia population. However, no studies have examined the feasibility, safety and efficacy of combining VR technology with verbal memory training among individuals with schizophrenia. Thus, in this study, we will adapt an exercise from the Strategy for Semantic Association Memory (SESAME; (Guimond et al., 2018; Guimond \& Lepage, 2016) training to a VR environment. We aim to determine the feasibility of using virtual reality in the context of a cognitive remediation intervention and to assess the initial efficacy of our verbal memory training on the use of semantic encoding strategies in people with schizophrenia. We also aim to assess participants' experience and tolerability of the VR training.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable schizophrenia
Started Feb 2019
Typical duration for not_applicable schizophrenia
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 12, 2019
CompletedFirst Submitted
Initial submission to the registry
January 27, 2020
CompletedFirst Posted
Study publicly available on registry
January 31, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 17, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 17, 2023
CompletedApril 14, 2023
April 1, 2023
4 years
January 27, 2020
April 13, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
Change in semantic encoding strategy use as measured by change in semantic clustering from baseline - the Hopkins Verbal Learning Test - Revisited (HVLT-R).
The Hopkins Verbal Learning Test - Revisited (HVLT-R) for verbal memory is a 12-item test to measure a person's ability to encode, combine, store and recover verbal information in memory.
baseline, post treatment (~20 minutes)
Feasibility of the intervention
Feasibility of the intervention as measured by the number of people who complete the intervention.
baseline, post treatment (~20 minutes)
Secondary Outcomes (3)
Change in verbal memory performance from baseline
baseline, post treatment (~20 minutes)
Participants' experience and tolerability - VR experience questionnaire
post treatment (~20 minutes)
Participants' experience - Simulator sickness questionnaire (SSQ)
post treatment (~20 minutes)
Study Arms (2)
Cognitive Intervention
EXPERIMENTALActive Control Intervention
ACTIVE COMPARATORInterventions
Participants will undergo 15 minutes of a cognitively challenging activity in the Virtual Reality environment. (More details about each condition will be added after study completion to protect the blinding of our participants).
Participants will undergo 15 minutes of a cognitively challenging activity in the Virtual Reality environment. (More details about each condition will be added after study completion to protect the blinding of our participants).
Eligibility Criteria
You may qualify if:
- age 20-60 years
- the ability to read and speak fluent English
- having a diagnosis of schizophrenia or schizoaffective from a psychiatrist and confirmed by the Mini International Neuropsychiatric Interview (M.I.N.I) interview
- considered clinically stable (on stable medication for more than one month, and have a score below 95 on the Positive and Negative Syndrome Scale (PANSS))
You may not qualify if:
- having vision problems that cannot be corrected with contact lenses or glasses that fit into the VR goggles (because of requirements of VR headset)
- having significant neurological or medical disorders (other than schizophrenia/schizoaffective disorder) that may produce cognitive impairment
- a recent history of substance abuse or dependence (within the past 3 months)
- decisional incapacity requiring a guardian
- having past or current conditions of seizure, epilepsy, migraines or cybersickness
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Royal Ottawa Mental Health Centre
Ottawa, Ontario, K1Z 7K4, Canada
Related Publications (2)
Guimond S, Lepage M. Cognitive training of self-initiation of semantic encoding strategies in schizophrenia: A pilot study. Neuropsychol Rehabil. 2016;26(3):464-79. doi: 10.1080/09602011.2015.1045526. Epub 2015 Jul 6.
PMID: 26145159RESULTGuimond S, Beland S, Lepage M. Strategy for Semantic Association Memory (SESAME) training: Effects on brain functioning in schizophrenia. Psychiatry Res Neuroimaging. 2018 Jan 30;271:50-58. doi: 10.1016/j.pscychresns.2017.10.010. Epub 2017 Oct 25.
PMID: 29102504RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Synthia Guimond, PhD
Royal Ottawa Mental Health Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Scientist
Study Record Dates
First Submitted
January 27, 2020
First Posted
January 31, 2020
Study Start
February 12, 2019
Primary Completion
February 17, 2023
Study Completion
February 17, 2023
Last Updated
April 14, 2023
Record last verified: 2023-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- SAP, ANALYTIC CODE
- Time Frame
- De-identified data will become available upon completion of the study and once results have been published in an academic journal (anticipated time frame: the year of 2021).
De-identified data collected from this study may be shared with other researchers at the Royal's Institute of Mental Health Research for analyses and re-analyses. Variables of the study and scripts used for analyses will be made available to the public. De-identified data will also be shared with the general public upon request. Data that can connect with participants' identity will NOT be used or shared for analyses.